ERAS

12 drugs in development·8 companies·2 clinical trials

Drug Pipeline by Phase

Approved(6)

Drug	Company
adcirca	ELI LILLY & Co (LLY)
deferasirox	Amneal Pharmaceuticals, Inc. (AMRX)
donepezil	DR REDDYS LABORATORIES LTD (RDY)
doxorubicin	Amneal Pharmaceuticals, Inc. (AMRX)
neostigmine methyl	Amphastar Pharmaceuticals, Inc. (AMPH)
trodelvy	Immunome Inc. (IMNM)

Phase 3(1)

Drug	Company
inz-701	Inozyme Pharma, Inc. (INZY)

Phase 4(5)

Drug	Company
Control	AIM ImmunoTech Inc. (AIM)
Control	Valneva SE (VALN)
Control group	Valneva SE (VALN)
Enhanced Recovery After Surgery	AIM ImmunoTech Inc. (AIM)
Enhanced Recovery After Surgery	Valneva SE (VALN)

BioSniper tracks 12 drugs in development for ERAS across 8 companies.

There are 2 clinical trials targeting ERAS tracked by BioSniper.

Full trial data, competitive analysis, and AI-powered pipeline tracking.